Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Promin, a brand of First Diet Limited, is a specialized medical nutrition company that focuses on the development and manufacture of low-protein foods for patients with inherited metabolic disorders. The company's product portfolio is primarily designed for individuals managing conditions such as Phenylketonuria (PKU), where strict dietary control of protein intake is essential for health. Promin offers a wide range of staple food alternatives, including low-protein pasta, bread mixes, and meat substitutes, to improve the quality of life and dietary compliance of patients. In 2011, the company was acquired by Vitaflo International, a subsidiary of Nestlé Health Science, further integrating its specialized products into a global clinical nutrition network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Promin.